Suchergebnisse - (Person:"Atagündüz, Pamir")

PubPharm (86)

51

The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?

enthalten in: Rheumatology | 2015

von Ozen, G. | Sunbul, M. | Atagunduz, P. | +3

52

Unmet need in Behcet's disease : most patients in routine follow-up continue to have oral ulcers

enthalten in: Clinical rheumatology | 2014

von Alibaz-Oner, F. | Mumcu, G. | Kubilay, Z. | +9

53

Unmet need in Behcet’s disease: most patients in routine follow-up continue to have oral ulcers

enthalten in: Clinical rheumatology | 2014

von Alibaz-Oner, F. | Mumcu, G. | Kubilay, Z. | +9

54

Unmet need in Behcet’s disease: most patients in routine follow-up continue to have oral ulcers

enthalten in: Clinical rheumatology | 2014

von Alibaz-Oner, F. | Mumcu, G. | Kubilay, Z. | +9

55

Unmet need in Behcet’s disease: most patients in routine follow-up continue to have oral ulcers

enthalten in: Clinical rheumatology | 2014

von Alibaz-Oner, F. | Mumcu, G. | Kubilay, Z. | +9

56

Sonographic measurement of Achilles tendon thickness in seronegative spondyloarthropathies

enthalten in: European journal of rheumatology | 2014

von Aydın, S. | Filippucci, E. | Atagündüz, P. | +3

57

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice : a single-centre experience

enthalten in: Clinical rheumatology | 2013

von Can, M. | Alibaz-Öner, F. | Yılmaz-Öner, S. | +3

58

Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients : a real-life experience

enthalten in: International journal of rheumatic diseases | 2012

von Can, M. | Aydın, S. | Niğdelioğlu, A. | +2

59

Conventional DMARD therapy (methotrexate‐sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real‐life experience

enthalten in: APLAR journal of rheumatology | 2012

von Can, M. | Aydın, S. | Niğdelioğlu, A. | +2

60

Conventional DMARD therapy (methotrexate‐sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real‐life experience

enthalten in: APLAR journal of rheumatology | 2012

von Can, M. | Aydın, S. | Niğdelioğlu, A. | +2